Literature DB >> 3306451

Acetylcholinesterase exhibits trypsin-like and metalloexopeptidase-like activity in cleaving a model peptide.

D H Small, Z Ismael, I W Chubb.   

Abstract

Acetylcholinesterase (EC 3.1.1.7) has been shown to possess an intrinsic peptidase activity. [Chubb et al. (1983), Neuroscience 10, 1369-1383]. To examine this activity further, the breakdown of a model hexapeptide (leu-trp-met-arg-phe-ala) LWMRFA was studied. Affinity-purified eel acetylcholinesterase rapidly cleaved the hexapeptide in a trypsin-like manner to produce two peptides (LWMR and FA). Acetylcholinesterase more slowly cleaved the C-terminal alanine residue from the peptide to yield LWMRF. Although the enzyme showed preference for cleaving the hexapeptide at its C-terminal, it was also able to cleave the N-terminal leucine residue form the tryptic product LWMR. Hydrolysis of the peptide at the tryptic site (arg4-phe5) was strongly inhibited by the trypsin inhibitor diisopropylfluorophosphate. Cleavage of the C-terminal alanine was only poorly inhibited by diisopropylfluorophosphate, but more strongly inhibited by metal-ion chelating agents, and it was increased in the presence of Zn2+ and Co2+. The pH optimum for cleavage at the tryptic site was 6, while that for the carboxypeptidase site was 8-9. These results show that acetylcholinesterase can hydrolyse peptides like a trypsin-like endopeptidase and a Zn2+- or Co2+-dependent exopeptidase, and they suggest that these two peptidase activities are associated with two separate active sites on the acetylcholinesterase molecule. As both peptidase activities eluted with acetylcholinesterase from a TSK 4000SW column when it was chromatographed by high-performance liquid chromatography, it is unlikely that the presence of either peptidase activity could be attributable to a contaminant in the acetylcholinesterase preparation. We suggest that acetylcholinesterase may be involved in the breakdown of bioactive peptides or their precursors in neuroendocrine cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3306451     DOI: 10.1016/0306-4522(87)90053-4

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  8 in total

Review 1.  Comparison of butyrylcholinesterase and acetylcholinesterase.

Authors:  A Chatonnet; O Lockridge
Journal:  Biochem J       Date:  1989-06-15       Impact factor: 3.857

2.  Protease inhibitors and indoleamines selectively inhibit cholinesterases in the histopathologic structures of Alzheimer disease.

Authors:  C I Wright; C Guela; M M Mesulam
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

3.  Cholinesterases colocalize with sites of neurofibrillary degeneration in aged and Alzheimer's brains.

Authors:  M A Morán; E J Mufson; P Gómez-Ramos
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

4.  Butyrylcholinesterase-Mediated enhancement of the enzymatic activity of trypsin.

Authors:  S Darvesh; R Kumar; S Roberts; R Walsh; E Martin
Journal:  Cell Mol Neurobiol       Date:  2001-06       Impact factor: 5.046

5.  Colocalization of cholinesterases with beta amyloid protein in aged and Alzheimer's brains.

Authors:  M A Morán; E J Mufson; P Gómez-Ramos
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

6.  Neuropeptide accretions in the endoplasmic reticulum of oxytocinergic neurons in cats, monkeys and rabbits: a widespread phenomenon.

Authors:  D V Pow
Journal:  J Anat       Date:  1992-08       Impact factor: 2.610

7.  The peptidase activity of human serum butyrylcholinesterase: studies using monoclonal antibodies and characterization of the peptidase.

Authors:  R V Rao; A S Balasubramanian
Journal:  J Protein Chem       Date:  1993-02

8.  Proteolysis at the secretase and amyloidogenic cleavage sites of the beta-amyloid precursor protein by acetylcholinesterase and butyrylcholinesterase using model peptide substrates.

Authors:  M de Serres; D Sherman; W Chestnut; B M Merrill; O H Viveros; E J Diliberto
Journal:  Cell Mol Neurobiol       Date:  1993-06       Impact factor: 5.046

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.